Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Michonneau

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Blood|July 12, 2022
Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapseViviane Gournay, Nicolas Vallet, Vivien Peux, et al.
Bone Marrow Transplantation|August 16, 2019
A monocentric study of steroid-refractory acute graft-versus-host disease treatment with tacrolimus and mTOR inhibitorAlienor Xhaard, Manon Launay, Flore Sicre de Fontbrune, et al.
Blood Advances|June 6, 2022
Prospective external validation of biomarkers to predict acute graft-versus-host disease severityMarie Robin, Raphael Porcher, David Michonneau, et al.
Transplantation and Cellular Therapy|April 1, 2021
Sexuality- and Fertility-Related Issues in Women after Allogeneic Hematopoietic Stem Cell TransplantationNathalie Forgeard, Matthieu Jestin, Dominique Vexiau, et al.
Blood Advances|January 4, 2018
Clinical profile, biological markers, and comorbidity index as predictors of transplant-related mortality after allo-HSCTAliénor Xhaard, Renato Cunha, Marc Busson, et al.
Haematologica|July 2, 2026
CPX-351 before allogeneic stem cell transplantation, a real-world French experienceEléonore Kaphan, Hélène Kemp, Nicolas Vallet, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 29, 2025
Lichenoid graft-versus-host disease shows a high interferon score, with IFNAR1 inhibition preventing skin inflammationChloé Grolleau, Thomas Poisot, Andreea Calugareanu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2018
Utility and Safety of Liver Biopsy in Patients with Undetermined Liver Blood Test Anomalies after Allogeneic Hematopoietic Stem Cell Transplantation: A Monocentric Retrospective Cohort StudyMathilde Ruggiu, Pierre Bedossa, Pierre Emmanuel Rautou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2020
Should Transplantation Still Be Considered for Ph1-Negative Myeloproliferative Neoplasms in Transformation?Mathilde Ruggiu, Bruno Cassinat, Jean-Jacques Kiladjian, et al.
European Journal of Dermatology : EJD|October 12, 2023
Graft-versus-lymphoma effect in skin after allogeneic hematopoietic stem cell transplantation for Sézary syndromeMerian Ranjbaryan, Julien Calvani, Baptiste Louveau, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Blood|July 12, 2022
Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapseViviane Gournay, Nicolas Vallet, Vivien Peux, et al.
Bone Marrow Transplantation|August 16, 2019
A monocentric study of steroid-refractory acute graft-versus-host disease treatment with tacrolimus and mTOR inhibitorAlienor Xhaard, Manon Launay, Flore Sicre de Fontbrune, et al.
Blood Advances|June 6, 2022
Prospective external validation of biomarkers to predict acute graft-versus-host disease severityMarie Robin, Raphael Porcher, David Michonneau, et al.
Transplantation and Cellular Therapy|April 1, 2021
Sexuality- and Fertility-Related Issues in Women after Allogeneic Hematopoietic Stem Cell TransplantationNathalie Forgeard, Matthieu Jestin, Dominique Vexiau, et al.
Blood Advances|January 4, 2018
Clinical profile, biological markers, and comorbidity index as predictors of transplant-related mortality after allo-HSCTAliénor Xhaard, Renato Cunha, Marc Busson, et al.
Haematologica|July 2, 2026
CPX-351 before allogeneic stem cell transplantation, a real-world French experienceEléonore Kaphan, Hélène Kemp, Nicolas Vallet, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 29, 2025
Lichenoid graft-versus-host disease shows a high interferon score, with IFNAR1 inhibition preventing skin inflammationChloé Grolleau, Thomas Poisot, Andreea Calugareanu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2018
Utility and Safety of Liver Biopsy in Patients with Undetermined Liver Blood Test Anomalies after Allogeneic Hematopoietic Stem Cell Transplantation: A Monocentric Retrospective Cohort StudyMathilde Ruggiu, Pierre Bedossa, Pierre Emmanuel Rautou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2020
Should Transplantation Still Be Considered for Ph1-Negative Myeloproliferative Neoplasms in Transformation?Mathilde Ruggiu, Bruno Cassinat, Jean-Jacques Kiladjian, et al.
European Journal of Dermatology : EJD|October 12, 2023
Graft-versus-lymphoma effect in skin after allogeneic hematopoietic stem cell transplantation for Sézary syndromeMerian Ranjbaryan, Julien Calvani, Baptiste Louveau, et al.
Pageof 11